Dr. Deng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109
Education & Training
West China University of Medical SciencesClass of 2015
Certifications & Licensure
WA State Medical License 2023 - 2026
NY State Medical License 2020 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Multi-Centered Pre-Treatment CT-Based Radiomics Features to Predict Locoregional Recurrence of Locally Advanced Esophageal Cancer After Definitive Chemoradiotherapy.Nuo Yu, Xiaolin Ge, Lijing Zuo, Ying Cao, Peipei Wang
Cancers. 2025-01-03 - Impact of locoregional recurrence versus distant metastasis on overall survival in patients with Non-Small cell lung cancer after Surgery: A secondary analysis of PORT...Zeliang Ma, Yunsong Liu, Yongxing Bao, Meiqi Wang, Xu Yang
Lung Cancer. 2025-01-01 - S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-wor...Xin Wang, Guojie Feng, Xiongtao Yang, Nuo Yu, Ziyu Zheng
Cancer Biology & Therapy. 2024-12-31
Press Mentions
Should First-Line Dual Checkpoint Blockade Be Used for NSCLC with Specific Mutations?October 24th, 2024- Cancer Today’s Summer 2024 Issue: Cardiovascular Toxicity, Immunotherapy in NSCLC, TILs, and MoreJune 25th, 2024
- New Signateratm MRD Data in Gastrointestinal Cancers to Be Presented at the ASCO GI Symposium 2023January 19th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
